A Comparative Evaluation of Diclofenac Sodium Transdermal Patch, Oral Diclofenac Sodium With Intramuscular Injections of Diclofenac Sodium in Patients Suffering From Oral Pain
Orofacial Pain
About this trial
This is an interventional treatment trial for Orofacial Pain
Eligibility Criteria
Inclusion Criteria:
- patients with oral and dental pain due to pulp and periapical pathology
- patients not allergic to any form of medications in terms of NSAIDs.
Exclusion Criteria:
- Unwilling and unconscious patients
- patients with cellulitis and spreading oral infections
- patients allergic to non steroidal anti inflammatory agents
- patients with kidney and liver diseases
- patients with blood disorders
Sites / Locations
- Panineeya Institute of Dental Sciences
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Experimental
Other
Diclofenac sodium oral
diclofenac sodium patch
Diclofenac sodium injection
Group A which included 30 patients of either gender. Dosage drug: Diclofenac sodium Dosage form: Oral medication Frequency: twice daily Dose: 50mg Duration: 2 days
Group B which included 30 patients who were prescribed Drug: Diclofenac sodium Dose: 100mg Drug form: transdermal patch to equate the oral dosage of 50mg Duration: for 2 days Frequency: Once daily
Group C which included 30 patients of either gender Drug: diclofenac sodium intra muscular injections Dose: 75mg which was the nearest available dosage to 100 mg availability in India Frequency: once daily Duration: for 2 days